type I IFN/CD40 costimulator (Evotec/Sanofi)

N/A

Report date: 2025/03/20 10:08:07

Base Information

Drug Nametype I IFN/CD40 costimulator (Evotec/Sanofi)
Drug Alias NameIFN-fused anti-CD40 antibody (Evotec/Sanofi)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonistsInterferon receptor type I agonists
TargetsTumor necrosis factor receptor superfamily member 5Interferon receptor type I
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvotec SE
China Registration ClassN/A

Develop Information

Active CompaniesSanofiEvotec SE
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A